Literature DB >> 26970983

Quantitative analysis of highly similar salvianolic acids with 1H qNMR for quality control of traditional Chinese medicinal preparation Salvianolate Lyophilized Injection.

Xialin Chen1, Yujie Guo1, Yuanjia Hu2, Boyang Yu3, Jin Qi4.   

Abstract

Salvianolate Lyophilized Injection (SLI), a traditional Chinese medicinal (TCM) preparation which is used to treat stroke, is composed of multiple salvianolic acids from the aqueous extracts of Salvia miltiorrhiza, and includes mainly protocatechualdehyde, rosmarinic acid, salvianolic acid B, salvianolic acid D, salvianolic acid E, diastereomer of salvianolic acid E, salvianolic acid Y, lithospermic acid and diastereomer of lithospermic acid. It is difficult to quantitatively control the quality of SLI using traditional high performance liquid chromatography due to the highly similar structure of these constituents including three pairs of diastereomers and the lack of commercial resources for most of these constituents as standards. Thus, a highly reproducible, fast, accurate and simple (1)H quantitative nuclear magnetic resonance (qNMR) method without the need for calibration curves and complex computation was established by optimizing the solvent system and acquisition parameters to simultaneously determine the nine salvianolic acids and mannitol in SLI. This method was validated and successfully used to determine 10 batches of SLI and the qNMR data were further analyzed with a vector including angle cosine and the partial least squares method for the quality control of SLI. The results indicated that qNMR can be used as a routine method for the quality control of SLI and may have potential in the quantification of diastereomers in other TCM preparations.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Diastereomer; Quality control; Salvianolate Lyophilized Injection; Salvianolic acids; Traditional Chinese medicine; qNMR

Mesh:

Substances:

Year:  2016        PMID: 26970983     DOI: 10.1016/j.jpba.2016.02.016

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Xueshuantong injection (lyophilized) combined with salvianolate lyophilized injection protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress.

Authors:  Fu-Jiang Wang; Shao-Xia Wang; Li-Juan Chai; Yue Zhang; Hong Guo; Li-Min Hu
Journal:  Acta Pharmacol Sin       Date:  2017-10-12       Impact factor: 6.150

2.  Neuroprotective effect of salvianolate lyophilized injection against cerebral ischemia in type 1 diabetic rats.

Authors:  Fujiang Wang; Qiansong He; Jinxin Wang; Qing Yuan; Hong Guo; Lijuan Chai; Shaoxia Wang; Limin Hu; Yue Zhang
Journal:  BMC Complement Altern Med       Date:  2017-05-10       Impact factor: 3.659

3.  Metabolic discrimination of sea buckthorn from different Hippophaë species by 1H NMR based metabolomics.

Authors:  Yue Liu; Gang Fan; Jing Zhang; Yi Zhang; Jingjian Li; Chao Xiong; Qi Zhang; Xiaodong Li; Xianrong Lai
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

Review 4.  Traditional Chinese Medicine Monomers: Novel Strategy for Endogenous Neural Stem Cells Activation After Stroke.

Authors:  Ju Wang; Jun Hu; Xuezhu Chen; Xuejiao Lei; Hua Feng; Feng Wan; Liang Tan
Journal:  Front Cell Neurosci       Date:  2021-02-26       Impact factor: 5.505

5.  A novel critical control point and chemical marker identification method for the multi-step process control of herbal medicines via NMR spectroscopy and chemometrics.

Authors:  Fang Zhao; Wenzhu Li; Jianyang Pan; Zeqi Chen; Haibin Qu
Journal:  RSC Adv       Date:  2020-06-23       Impact factor: 4.036

6.  Quality Evaluation of the Traditional Medicine Majun Mupakhi ELA via Chromatographic Fingerprinting Coupled with UHPLC-DAD-Quadrupole-Orbitrap-MS and the Antioxidant Activity In Vitro.

Authors:  Ayinuer Reheman; Haji Akber Aisa; Qing Ling Ma; Dilaram Nijat; Rahima Abdulla
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-06       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.